Overview

To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg

Status:
Completed
Trial end date:
2000-11-01
Target enrollment:
Participant gender:
Summary
To demonstrate the relative bioavailability of atenolol tablets, 100 mg.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Atenolol